OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 615 citing articles:

Guidelines for the Evaluation and Management of Status Epilepticus
Gretchen M. Brophy, Rodney Bell, Jan Claassen, et al.
Neurocritical Care (2012) Vol. 17, Iss. 1, pp. 3-23
Closed Access | Times Cited: 1461

Magnesium in Man: Implications for Health and Disease
Jeroen H. F. de Baaij, Joost G.J. Hoenderop, René J.M. Bindels
Physiological Reviews (2014) Vol. 95, Iss. 1, pp. 1-46
Closed Access | Times Cited: 1422

Recent advances in epilepsy
Mark Manford
Journal of Neurology (2017) Vol. 264, Iss. 8, pp. 1811-1824
Open Access | Times Cited: 245

Blood–brain barrier dysfunction and epilepsy: Pathophysiologic role and therapeutic approaches
Nicola Marchi, Tiziana Granata, Chaitali Ghosh, et al.
Epilepsia (2012) Vol. 53, Iss. 11, pp. 1877-1886
Open Access | Times Cited: 243

Predictors of Outcome in Refractory Status Epilepticus
Sara E. Hocker, Jeffrey W. Britton, Jayawant N. Mandrekar, et al.
JAMA Neurology (2013) Vol. 70, Iss. 1, pp. 72-72
Closed Access | Times Cited: 230

25 years of advances in the definition, classification and treatment of status epilepticus
Eugen Trinka, Reetta Kälviäinen
Seizure (2016) Vol. 44, pp. 65-73
Closed Access | Times Cited: 203

Pharmacotherapy for Status Epilepticus
Eugen Trinka, Julia Höfler, Markus Leitinger, et al.
Drugs (2015) Vol. 75, Iss. 13, pp. 1499-1521
Open Access | Times Cited: 199

Costs, length of stay, and mortality of super‐refractory status epilepticus: A population‐based study from Germany
Adam Strzelczyk, Sonja Ansorge, Jana Hapfelmeier, et al.
Epilepsia (2017) Vol. 58, Iss. 9, pp. 1533-1541
Open Access | Times Cited: 178

Adult epilepsy
Ali A. Asadi‐Pooya, Francesco Brigo, Simona Lattanzi, et al.
The Lancet (2023) Vol. 402, Iss. 10399, pp. 412-424
Closed Access | Times Cited: 108

Causes of status epilepticus
Eugen Trinka, Julia Höfler, Alexander Zerbs
Epilepsia (2012) Vol. 53, Iss. s4, pp. 127-138
Closed Access | Times Cited: 185

Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood–brain barrier leakage but not microglia activation
Erwin A. van Vliet, Grazia Forte, Linda Holtman, et al.
Epilepsia (2012) Vol. 53, Iss. 7, pp. 1254-1263
Closed Access | Times Cited: 164

Hypothermia for Neuroprotection in Convulsive Status Epilepticus
Stéphane Legriel, Virginie Lemiale, Maleka Schenck, et al.
New England Journal of Medicine (2016) Vol. 375, Iss. 25, pp. 2457-2467
Open Access | Times Cited: 160

Super‐refractory status epilepticus: An approach to therapy in this difficult clinical situation
Simon Shorvon
Epilepsia (2011) Vol. 52, Iss. s8, pp. 53-56
Closed Access | Times Cited: 144

Febrile Infection–Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis
Annamaria Vezzani, Martin Häusler, Gerhard Kluger, et al.
Neuropediatrics (2016) Vol. 48, Iss. 01, pp. 005-018
Open Access | Times Cited: 125

Lacosamide in status epilepticus: Systematic review of current evidence
Adam Strzelczyk, Johann Philipp Zöllner, Laurent M. Willems, et al.
Epilepsia (2017) Vol. 58, Iss. 6, pp. 933-950
Open Access | Times Cited: 125

Pathophysiology of status epilepticus
Matthew C. Walker
Neuroscience Letters (2016) Vol. 667, pp. 84-91
Open Access | Times Cited: 124

New-onset refractory status epilepticus (NORSE) — The potential role for immunotherapy
Ayaz Khawaja, Jennifer DeWolfe, David W. Miller, et al.
Epilepsy & Behavior (2015) Vol. 47, pp. 17-23
Closed Access | Times Cited: 119

Pediatric super‐refractory status epilepticus treated with allopregnanolone
Eileen Broomall, JoAnne E. Natale, Michele Grimason, et al.
Annals of Neurology (2014) Vol. 76, Iss. 6, pp. 911-915
Open Access | Times Cited: 117

Seizure outcomes in patients with anti‐NMDARencephalitis: A follow‐up study
Xu Liu, Bo Yan, Rui Wang, et al.
Epilepsia (2017) Vol. 58, Iss. 12, pp. 2104-2111
Open Access | Times Cited: 113

Incidence and mortality of super-refractory status epilepticus in adults
Anne-Mari Kantanen, Matti Reinikainen, Ilkka Parviainen, et al.
Epilepsy & Behavior (2015) Vol. 49, pp. 131-134
Closed Access | Times Cited: 110

Guidelines for the diagnosis and treatment of acute encephalopathy in childhood
Masashi Mizuguchi, Takashi Ichiyama, George Imataka, et al.
Brain and Development (2020) Vol. 43, Iss. 1, pp. 2-31
Open Access | Times Cited: 110

Establishing an Adult Epilepsy Diet Center: Experience, efficacy and challenges
Mackenzie C. Cervenka, Bobbie J. Henry-Barron, Elizabeth A. Felton, et al.
Epilepsy & Behavior (2016) Vol. 58, pp. 61-68
Open Access | Times Cited: 108

Refractory and super-refractory status epilepticus in adults: a 9-year cohort study
L. Delaj, Jan Nový, Philippe Ryvlin, et al.
Acta Neurologica Scandinavica (2016) Vol. 135, Iss. 1, pp. 92-99
Open Access | Times Cited: 108

Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus
Eva M. Jiménez‐Mateos, Tobías Engel, Paula Merino-Serráis, et al.
Brain Structure and Function (2014) Vol. 220, Iss. 4, pp. 2387-2399
Closed Access | Times Cited: 103

Page 1 - Next Page

Scroll to top